Cryoprobe Versus Forceps for Transbronchial Biopsy (FROSTBITE-2)
A Randomized Trial of Cryoprobe Versus Forceps for Transbronchial Biopsy
Sponsor: Erbe USA Incorporated
Listed as NCT05751278, this NA trial focuses on Lung Diseases and remains ongoing. Sponsored by Erbe USA Incorporated, it has been updated 9 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Jan 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Enrolling By Invitation NA
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation NA
▶ Show 4 earlier versions
-
Jan 2024 — Jul 2024 [monthly]
Enrolling By Invitation NA
-
Sep 2023 — Jan 2024 [monthly]
Enrolling By Invitation NA
-
May 2023 — Sep 2023 [monthly]
Enrolling By Invitation NA
-
Apr 2023 — May 2023 [monthly]
Enrolling By Invitation NA
First recorded
Feb 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Erbe USA Incorporated
- Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .